ADVANCED NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer patients: experimental drug shows promise in early trial
Disease control CompletedThis study tested a new drug called AZD9291 in 603 people with advanced non-small cell lung cancer whose tumors had started growing again after previous targeted therapy. The main goals were to find the safest and most effective dose, measure how the drug moves through the body, …
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
Simple blood test may spot lung cancer gene mutations
Diagnosis CompletedThis study looked at whether a blood test can find gene changes in people with advanced lung cancer. 22 adults with advanced non-small cell lung cancer gave a blood sample. The test was compared to standard tissue tests to see if it works well enough for everyday use.
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Diagnosis
Last updated May 07, 2026 18:41 UTC
-
Lung cancer drug interaction study completed
Knowledge-focused CompletedThis study looked at how the antifungal drug itraconazole changes the levels of the lung cancer drug AZD9291 in the body. It involved 39 adults with advanced EGFR-mutant non-small cell lung cancer whose disease had worsened after previous treatments. The goal was to understand th…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 00:49 UTC